2877 — China Shineway Pharmaceutical Cashflow Statement
0.000.00%
Last trade - 00:00- HK$8.07bn
- -HK$160.20m
- CNY3.14bn
Annual cashflow statement for China Shineway Pharmaceutical, fiscal year end - December 31st, CNY millions except per share, conversion factor applied.
2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | 2025 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | — |
| Source: | ARS | ARS | ARS | ARS | |
| Standards: | IFRS | IFRS | IFRS | IFRS | — |
| Status: | Final | Final | Final | Final | fx Preliminary |
| Net Income/Starting Line | 720 | 917 | 1,240 | 1,146 | — |
| Depreciation | |||||
| Amortisation | |||||
| Non-Cash Items | -98 | -126 | -120 | -145 | — |
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | -101 | 133 | -365 | -106 | — |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Prepaid Expenses | |||||
| Change in Accounts Payable | |||||
| Change in Other Liabilities | |||||
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | 703 | 1,110 | 933 | 963 | — |
| Capital Expenditures | -93.6 | -129 | -144 | -140 | — |
| Purchase of Fixed Assets | |||||
| Other Investing Cash Flow Items | 489 | 84 | 94.8 | -132 | — |
| Acquisition of Business | |||||
| Sale of Business | |||||
| Sale of Fixed Assets | |||||
| Sale/Maturity of Investment | |||||
| Change in Net Investments | |||||
| Purchase of Investments | |||||
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | 395 | -45.4 | -49.5 | -272 | — |
| Financing Cash Flow Items | 1.17 | -0.63 | -2.6 | -6.27 | — |
| Other Financing Cash Flow | |||||
| Total Cash Dividends Paid | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | -829 | -250 | -26.7 | -392 | — |
| Foreign Exchange Effects | |||||
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 263 | 821 | 863 | 251 | — |